Evidence map›Paper›PMID 37997648›Full record

SynthesisCancer reports (Hoboken, N.J.)2024

Prognostic value of red blood cell distribution width and D-Dimer in diffuse large B-cell lymphoma: Systematic review and meta-analysis.

Maryam Rahchamani, Mohammad Sedghi, Ali Hakimi, Mahdi Nejatianfar, Tohid Javaheri, Reza Tavakoli, Ramtin Ahmadi, Mansoureh Makarem, Nazanin Azmi-Naei, Saeid Zahmatkesh Sangani and 5 more

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Cancer reports (Hoboken, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Red Cell Distribution Width in Diffuse Large B-cell Lymphoma.Asian Pacific journal of cancer prevention : APJCP · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 1 country.

Maryam RahchamaniDepartment of Internal Medicine, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad SedghiMolecular and Cellular Biology, Department of Biology, Yadegar-e-Imam Khomeini (RAH) Shahr-e-Ray Branch, Islamic Azad University, Tehran, Iran.
Ali HakimiDepartment of Clinical Biochemistry, Mashhad University of Medical Sciences, Mashhad, Iran.
Mahdi NejatianfarDepartment of Research and Development, Organic Chemistry Hila Pharmaceutical Co, Mashhad, Iran.
Tohid JavaheriDepartment of Genetics, Young Research and Elites Club, Islamic Azad University, Mashhad Branch, Mashhad, Iran.
Reza TavakoliDepartment of Radiology, Arak University of Medical Sciences, Arak, Iran.
Ramtin AhmadiCellular and Molecular, Islamic Azad University of Mashhad, Mashhad, Iran.
Mansoureh MakaremHealth Vice-Chancellor, Torbat-e Jam Faculty of Medical Sciences, Torbat-e Jam, Iran.
Nazanin Azmi-NaeiDepartment of Epidemiology, School of Public Health, Shahroud University of Medical Sciences, Shahroud, Iran.
Saeid Zahmatkesh SanganiHealth Vice-Chancellor, Torbat-e Jam Faculty of Medical Sciences, Torbat-e Jam, Iran.
Neda KamandiFaculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
AmirMohammad SoleimanianFaculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Rasoul ShavalehDepartment of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
Molood FoogerdiDepartment of Emergency Medicine, Faculty of Medicine, Birgand University of Medical Sciences, Birjand, Iran.ORCID 0000-0002-5476-4001
Kazem RahmaniDepartment of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
Mashhad University of Medical Sciences · IRIran University of Medical Sciences · IRIslamic Azad University, Mashhad · IRTorbat Heydarieh University of Medical Sciences · IRArak University of Medical Sciences · IRBirjand University of Medical Sciences · IRIslamic Azad University, Tehran · IRShahroud University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe significant role of red blood cell distribution width (RDW) and D-Dimer as prognostic factors in patients with some blood malignancies has been reported recently.

aimWe designed and performed a meta-analysis to investigate the prognostic roles of RDW and D-Dimer in subjects with diffuse large B-cell lymphoma (DLBCL). MATERIALS AND

methodsWe systematically reviewed PubMed-Medline, SCOPUS, EMBASE, Web of Science Core Collection, and Google Scholar up to the present to look for publications on prognostic effects of RDW and D-Dimer in DLBCL patients. For investigation of the associations between RDW and D-Dimer with the overall survival (OS) and progression-free survival (PFS) of the DLBCL cases, hazard ratio (HR) with 95% confidence intervals (CIs) was used.

resultsWe included 13 eligible studies in the present meta-analysis. The results of pooled analysis showed that increased levels of RDW was related to poor OS (HR = 2.01, 95% CI: 1.62-2.48, p value <.01, I

conclusionOur finding clearly confirmed that elevated RDW levels and D-Dimer were associated with adverse OS and PFS in DLBCL.

Indexed as

Erythrocyte IndicesFibrin Fibrinogen Degradation ProductsLymphoma, Large B-Cell, DiffuseErythrocytesHumansPrognosisFibrin Fibrinogen Degradation Productsfibrin fragment DD-DimerDLBCLnon-Hodgkin's lymphomaprognosisRDW

Identifiers

PMID37997648
PMCPMC10809198
OpenAlexW4388982135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.